查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2028 年欧洲药物输送市场预测 - COVID-19 影响和区域分析 - 按给药途径、配销通路和最终用户
市场调查报告书
商品编码
1375079

2028 年欧洲药物输送市场预测 - COVID-19 影响和区域分析 - 按给药途径、配销通路和最终用户

Europe Drug Delivery Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Route of Administration, Distribution Channel, and End User
出版日期: | 出版商: The Insight Partners | 英文 247 Pages | 订单完成后即时交付

价格

欧洲给药市场预计将从2023年的6322.6846亿美元成长到2028年的8953.3887亿美元。预计2023年至2028年复合年增长率为7.2%。

对非侵入性给药系统不断增长的需求推动了欧洲给药市场

非侵入性药物递送通常是指穿过黏膜表面或皮肤的生物屏障的无痛药物递送方法。这种药物传递方法可以改善药物的取得、治疗方案的依从性以及更好的药物安全性。由于与注射给药相比具有明显的优势，患者更喜欢非侵入性给药途径。研究发现，透过非侵入性方法给药时，患者的依从性要高得多，因为他们在手术过程中感受到的疼痛减轻了。随着医疗设备和透皮给药技术的改进，非侵入性给药方式现已准备好与传统的口服和注射给药途径竞争。局部给药、经皮主动给药（装置辅助增强渗透）、透皮被动给药、经眼膜、跨黏膜以及吸入药物经由肺泡膜给药是一些流行的非侵入性给药方法。

低排斥率、易于给药、便利性和耐用性使 TDDS 成为最具吸引力的药物传递方法。除了医疗机构的药物管理之外，TDDS 还可用于护肤行业的不同程序。由于此方法主要涉及局部给药，因此可以防止药物非特异性地递送至非标靶组织。 TDDS 的发展可能有助于控制心血管和中枢神经系统疾病、遗传性疾病、糖尿病、神经肌肉疾病和传染病（包括局部疾病）的盛行率，同时推动疫苗接种的进步和患者对长期自我给药的偏好- 长期治疗。

透过非侵入性方法输送药物涉及减少给药频率和简化给药方案。此外，这些输送系统可以显着降低临床使用成本，因为患者可以透过这些方法自行给药。在许多情况下，采用非侵入性给药系统的药物的製造成本低于注射剂的生产成本。例如，吸入胰岛素已成为治疗糖尿病的耐受性良好且首选的方式。因此，对非侵入性药物输送系统不断增长的需求推动了药物输送系统市场的成长。

欧洲药物输送市场概况

欧洲给药市场细分为德国、法国、义大利、英国、西班牙和欧洲其他地区。该地区的市场成长与慢性病发病率的上升、老年人口的增加、市场参与者的扩张策略以及製药业的成长有关。德国以其技术进步而闻名，在医疗保健领域处于领先地位。 Haselmeier 等德国公司开发了 D-Flex 笔，这是一种比以前开发的注射笔更有效的药物输送装置。该笔是用于皮下自我注射的下一代药物输送装置。多剂量固定笔可以单次固定剂量或多个预设剂量给药；因此，它优于传统的药物输送装置。

欧洲给药市场收入及 2028 年预测（百万美元）

欧洲药物输送市场细分

欧洲给药市场分为给药途径、配销通路、最终用户和国家。

根据给药途径，欧洲给药市场分为注射给药、口服给药、经黏膜给药、局部给药、植入式给药及眼部给药。 2023年，注射给药细分市场在欧洲给药市场中占有更大份额。

根据配销通路，欧洲给药市场分为医院药房、零售药房和线上药房。 2023 年，医院药局领域在欧洲给药市场中占据最大份额。

根据最终用户，欧洲给药市场分为医院和诊所、家庭护理机构和其他最终用户。 2023 年，医院和诊所领域在欧洲给药市场中占最大份额。

根据国家/地区，欧洲给药市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2023年，德国在欧洲给药市场份额中占据主导地位。

博士健康公司；百特国际公司；贝克顿·迪金森公司；勃林格殷格翰国际股份有限公司；波士顿科学公司；格雷斯海默股份公司；葛兰素史克公司；强生公司；诺华公司；诺和诺德公司；辉瑞公司；和 Sever Pharma Solutions 是欧洲给药市场的领导公司。

目录

第 1 章：简介

  • 研究范围
  • Insight Partners 研究报告指南
  • 市场区隔
    • 欧洲药物输送市场 - 按给药途径
    • 欧洲药物输送市场 - 按配销通路
    • 欧洲药物输送市场 - 按最终用户划分
    • 欧洲药物输送市场 - 按国家/地区

第 2 章：欧洲药物输送市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲药物输送市场 - 市场格局

  • 概述
  • 欧洲PEST分析
  • 专家意见

第 5 章：欧洲药物输送市场 - 主要市场动态

  • 市场驱动因素
    • 慢性病发生率上升
    • 对非侵入性给药系统的需求不断增长
    • 药厂研发支出增加
  • 主要市场限制
    • 与药物和输送系统开发相关的高成本
    • 药物输送系统中的产品召回
  • 主要市场机会
    • 专注于提高病患依从性
  • 未来的趋势
    • 策略发展和产品发布
  • 影响分析

第 6 章：药物输送市场 - 欧洲分析

  • 欧洲给药市场收入预测与分析

第 7 章：欧洲药物输送市场 - 2028 年收入和预测 - 按给药途径

  • 概述
  • 欧洲药物输送市场收入份额，依给药途径划分（2022 年和 2028 年）
  • 注射给药
  • 口服给药
  • 局部给药
  • 经由黏膜给药
  • 植入式药物输送
  • 眼部药物输送

第 8 章：欧洲药物输送市场 - 收入和 2028 年预测 - 按配销通路

  • 概述
  • 欧洲药物输送系统市场收入份额，按配销通路划分（2022 年和 2028 年）
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章：欧洲药物输送市场 - 收入和 2028 年预测 - 按最终用户

  • 概述
  • 欧洲药物输送系统市场收入份额，按最终用户划分（2022 年和 2028 年）
  • 医院和诊所
  • 家庭护理设置
  • 其他最终用户

第 10 章：欧洲药物输送市场 - 2028 年收入与预测 - 国家分析

      • 英国
      • 德国
      • 法国
      • 西班牙
      • 义大利
      • 欧洲其他地区

第 11 章：欧洲药物输送市场 - 产业格局

  • 概述
  • 欧洲给药市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Becton Dickinson and Co
  • Novo Nordisk AS
  • Boston Scientific Corp
  • Baxter International Inc
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • 博士健康公司
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展
  • 勃林格殷格翰国际股份有限公司
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展
  • 诺华公司
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展
  • 塞弗製药解决方案
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展
  • 强生公司
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展
  • 辉瑞公司
    • 主要事实
    • 业务描述
    • 产品与服务
    • 财务概览
    • SWOT分析
    • 主要进展

    第 13 章：附录

    • 关于 Insight Partners
    • 专业术语
    • Product Code: BMIRE00028754

    The Europe drug delivery market is expected to grow from US$ 6,32,268.46 million in 2023 to US$ 8,95,338.87 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2023 to 2028.

    Growing Demand for Noninvasive Drug Delivery Systems Fuel Europe Drug Delivery Market

    Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

    A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

    Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

    Europe Drug Delivery Market Overview

    The Europe drug delivery market is sub segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth in this region is associated with rise in incidences of chronic diseases, increase in the geriatric population, expansion strategies by the market players, and growth of the pharmaceutical industry. Germany is known for its technological advancements, leading the country to the forefront in the medical & healthcare sectors. German companies such as Haselmeier have developed the D-Flex pen, a drug delivery device that works more efficiently than previously developed injection pens. The pen is the next-generation drug delivery device for subcutaneous self-injection. The multi-dose fixed pen can administer the drug in a single fixed dose or several pre-set doses; therefore, it is preferred over conventional drug delivery devices.

    Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

    Europe Drug Delivery Market Segmentation

    The Europe drug delivery market is segmented into route of administration, distribution channel, end user, and country.

    Based on route of administration, the Europe drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Europe drug delivery market in 2023.

    Based on distribution channel, the Europe drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Europe drug delivery market in 2023.

    Based on end user, the Europe drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the Europe drug delivery market in 2023.

    Based on country, the Europe drug delivery market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe drug delivery market in 2023.

    Bausch Health Companies Inc; Baxter International Inc; Becton Dickinson and Co; Boehringer Ingelheim International GmbH; Boston Scientific Corp; Gerresheimer AG; GlaxoSmithKline Plc; Johnson & Johnson; Novartis AG; Novo Nordisk AS; Pfizer Inc; and Sever Pharma Solutions are the leading companies operating in the Europe drug delivery market.

    Reasons to Buy:

    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe drug delivery market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in Europe drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

    Table Of Contents

    1. Introduction

    • 1.1 Study Scope
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Europe Drug Delivery Market - by Route of Administration
      • 1.3.2 Europe Drug Delivery Market - by Distribution Channel
      • 1.3.3 Europe Drug Delivery Market - by End User
      • 1.3.4 Europe Drug Delivery Market - by Country

    2. Europe Drug Delivery Market - Key Takeaways

    3. Research Methodology

    • 3.1 Coverage
    • 3.2 Secondary Research
    • 3.3 Primary Research

    4. Europe Drug Delivery Market - Market Landscape

    • 4.1 Overview
    • 4.2 Europe PEST Analysis
    • 4.3 Expert's Opinion

    5. Europe Drug Delivery Market - Key Market Dynamics

    • 5.1 Market Drivers
      • 5.1.1 Rising Incidence of Chronic Diseases
      • 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
      • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
    • 5.2 Key Market Restraints
      • 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
      • 5.2.2 Product Recalls in Drug Delivery Systems
    • 5.3 Key Market Opportunities
      • 5.3.1 Focus on Improving Patient Compliance
    • 5.4 Future Trends
      • 5.4.1 Strategic Developments and Product Launches
    • 5.5 Impact analysis

    6. Drug Delivery Market -Europe Analysis

    • 6.1 Europe Drug Delivery Market Revenue Forecast and Analysis

    7. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

    • 7.1 Overview
    • 7.2 Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • 7.3 Injectable Drug Delivery
      • 7.3.1 Overview
      • 7.3.2 Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.1 Conventional Injection Devices
          • 7.3.2.1.1 Overview
          • 7.3.2.1.2 Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.2 Advanced Devices
          • 7.3.2.2.1 Overview
          • 7.3.2.2.2 Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4 Oral Drug Delivery
      • 7.4.1 Overview
      • 7.4.2 Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.1 Solid Oral Drugs
          • 7.4.2.1.1 Overview
          • 7.4.2.1.2 Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.2 Liquid Oral Drugs
          • 7.4.2.2.1 Overview
          • 7.4.2.2.2 Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.3 Semi-solid Oral Drugs
          • 7.4.2.3.1 Overview
          • 7.4.2.3.2 Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5 Topical Drug Delivery
      • 7.5.1 Overview
      • 7.5.2 Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1 Semi-solid Topical Drug Delivery
          • 7.5.2.1.1 Overview
          • 7.5.2.1.2 Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.2 Liquid Topical Drug Delivery Formulations
          • 7.5.2.2.1 Overview
          • 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.3 Solid Topical Drug Delivery Formulations
          • 7.5.2.3.1 Overview
          • 7.5.2.3.2 Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.4 Transdermal
          • 7.5.2.4.1 Overview
          • 7.5.2.4.2 Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.6 Transmucosal Drug Delivery
      • 7.6.1 Overview
      • 7.6.2 Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.1 Pulmonary and Nasal Drug Delivery
          • 7.6.2.1.1 Overview
          • 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.2 Buccal and Sublingual Drug Delivery
          • 7.6.2.2.1 Overview
          • 7.6.2.2.2 Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.3 Rectal Transmucosal Drug Delivery
          • 7.6.2.3.1 Overview
          • 7.6.2.3.2 Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.4 Vaginal Transmucosal Drug Delivery
          • 7.6.2.4.1 Overview
          • 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.7 Implantable Drug Delivery
      • 7.7.1 Overview
      • 7.7.2 Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.8 Ocular Drug Delivery
      • 7.8.1 Overview
      • 7.8.2 Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.1 Eye Drops and Sprays
          • 7.8.2.1.1 Overview
          • 7.8.2.1.2 Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.2 Gels and Ointments
          • 7.8.2.2.1 Overview
          • 7.8.2.2.2 Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.3 Ocular Inserts and Punctal Plugs
          • 7.8.2.3.1 Overview
          • 7.8.2.3.2 Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.4 Therapeutic Contact Lens
          • 7.8.2.4.1 Overview
          • 7.8.2.4.2 Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

    8. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

    • 8.1 Overview
    • 8.2 Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • 8.3 Hospital Pharmacies
      • 8.3.1 Overview
      • 8.3.2 Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4 Retail Pharmacies
      • 8.4.1 Overview
      • 8.4.2 Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.5 Online Pharmacies
      • 8.5.1 Overview
      • 8.5.2 Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    9. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By End User

    • 9.1 Overview
    • 9.2 Europe Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
    • 9.3 Hospitals and Clinics
      • 9.3.1 Overview
      • 9.3.2 Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4 Home Care Settings
      • 9.4.1 Overview
      • 9.4.2 Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.5 Other End User
      • 9.5.1 Overview
      • 9.5.2 Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    10. Europe Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

    • 10.1 Overview
      • 10.1.1 Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
        • 10.1.1.1 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.1 Overview
          • 10.1.1.1.2 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.3 UK: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.1.3.1 UK: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.2 UK: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.3 UK: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.4 UK: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.5 UK: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.4 UK: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.1.5 UK: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.1 Overview
          • 10.1.1.2.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.3 Germany: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.2.3.1 Germany: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.2 Germany: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.3 Germany: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.4 Germany: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.5 Germany: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.4 Germany: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.2.5 Germany: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.3 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.1 Overview
          • 10.1.1.3.2 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.3 France: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.3.3.1 France: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.2 France: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.3 France: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.4 France: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.5 France: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.4 France: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.3.5 France: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.4 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.4.1 Overview
          • 10.1.1.4.2 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.4.3 Spain: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.4.3.1 Spain: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.2 Spain: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.3 Spain: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.4 Spain: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.5 Spain: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.4 Spain: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.4.5 Spain: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.5 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.5.1 Overview
          • 10.1.1.5.2 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.5.3 Italy: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.5.3.1 Italy: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.2 Italy: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.3 Italy: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.4 Italy: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.5 Italy: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.4 Italy: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.5.5 Italy: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.6 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.6.1 Overview
          • 10.1.1.6.2 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.6.3 Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.6.3.1 Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.2 Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.3 Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.4 Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.5 Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.4 Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.6.5 Rest of Europe: Europe Drug Delivery Systems Market, by End User 2020-2028 (US$ Million)

    11. Europe Drug Delivery Market - Industry Landscape

    • 11.1 Overview
    • 11.2 Growth Strategies in Europe Drug Delivery Market
    • 11.3 Organic Growth Strategies
      • 11.3.1 Overview
    • 11.4 Inorganic Growth Strategies
      • 11.4.1 Overview

    12. Company Profiles

    • 12.1 Becton Dickinson and Co
      • 12.1.1 Key Facts
      • 12.1.2 Business Description
      • 12.1.3 Products and Services
      • 12.1.4 Financial Overview
      • 12.1.5 SWOT Analysis
      • 12.1.6 Key Developments
    • 12.2 Novo Nordisk AS
      • 12.2.1 Key Facts
      • 12.2.2 Business Description
      • 12.2.3 Products and Services
      • 12.2.4 Financial Overview
      • 12.2.5 SWOT Analysis
      • 12.2.6 Key Developments
    • 12.3 Boston Scientific Corp
      • 12.3.1 Key Facts
      • 12.3.2 Business Description
      • 12.3.3 Products and Services
      • 12.3.4 Financial Overview
      • 12.3.5 SWOT Analysis
      • 12.3.6 Key Developments
    • 12.4 Baxter International Inc
      • 12.4.1 Key Facts
      • 12.4.2 Business Description
      • 12.4.3 Products and Services
      • 12.4.4 Financial Overview
      • 12.4.5 SWOT Analysis
      • 12.4.6 Key Developments
    • 12.5 Gerresheimer AG
      • 12.5.1 Key Facts
      • 12.5.2 Business Description
      • 12.5.3 Products and Services
      • 12.5.4 Financial Overview
      • 12.5.5 SWOT Analysis
      • 12.5.6 Key Developments
    • 12.6 GlaxoSmithKline Plc
      • 12.6.1 Key Facts
      • 12.6.2 Business Description
      • 12.6.3 Products and Services
      • 12.6.4 Financial Overview
      • 12.6.5 SWOT Analysis
        • 12.6.5.1 Key Developments
    • 12.7 Bausch Health Companies Inc
      • 12.7.1 Key Facts
      • 12.7.2 Business Description
      • 12.7.3 Products and Services
      • 12.7.4 Financial Overview
      • 12.7.5 SWOT Analysis
      • 12.7.6 Key Developments
    • 12.8 Boehringer Ingelheim International GmbH
      • 12.8.1 Key Facts
      • 12.8.2 Business Description
      • 12.8.3 Products and Services
      • 12.8.4 Financial Overview
      • 12.8.5 SWOT Analysis
      • 12.8.6 Key Developments
    • 12.9 Novartis AG
      • 12.9.1 Key Facts
      • 12.9.2 Business Description
      • 12.9.3 Products and Services
      • 12.9.4 Financial Overview
      • 12.9.5 SWOT Analysis
      • 12.9.6 Key Developments
    • 12.10 Sever Pharma Solutions
      • 12.10.1 Key Facts
      • 12.10.2 Business Description
      • 12.10.3 Products and Services
      • 12.10.4 Financial Overview
      • 12.10.5 SWOT Analysis
      • 12.10.6 Key Developments
    • 12.11 Johnson & Johnson
      • 12.11.1 Key Facts
      • 12.11.2 Business Description
      • 12.11.3 Products and Services
      • 12.11.4 Financial Overview
      • 12.11.5 SWOT Analysis
      • 12.11.6 Key Developments
    • 12.12 Pfizer Inc
      • 12.12.1 Key Facts
      • 12.12.2 Business Description
      • 12.12.3 Products and Services
      • 12.12.4 Financial Overview
      • 12.12.5 SWOT Analysis
      • 12.12.6 Key Developments

    13. Appendix

    • 13.1 About The Insight Partners
    • 13.2 Glossary of Terms

    List Of Tables

    • Table 1. UK: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 2. UK: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 3. UK: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 4. UK: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 5. UK: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 6. UK: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 7. UK: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 8. UK: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 9. Germany: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 10. Germany: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 11. Germany: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 12. Germany: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 13. Germany: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 14. Germany: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 15. Germany: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 16. Germany: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 17. France: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 18. France: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 19. France: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 20. France: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 21. France: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 22. France: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 23. France: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 24. France: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 25. Spain: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 26. Spain: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 27. Spain: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 28. Spain: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 29. Spain: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 30. Spain: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 31. Spain: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 32. Spain: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 33. Italy: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 34. Italy: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 35. Italy: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 36. Italy: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 37. Italy: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 38. Italy: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 39. Italy: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 40. Italy: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 41. Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 42. Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 43. Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 44. Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 45. Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 46. Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 47. Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 48. Rest of Europe: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 49. Recent Organic Growth Strategies in Europe Drug Delivery Market
    • Table 50. Recent Inorganic Growth Strategies in the Europe Drug Delivery Market
    • Table 51. Glossary of Terms, Europe Drug delivery market

    List Of Figures

    • Figure 1. Europe Drug Delivery Market Segmentation
    • Figure 2. Europe Drug Delivery Market by Country
    • Figure 3. Europe Drug Delivery Market Overview
    • Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Europe Drug Delivery Market
    • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
    • Figure 6. Europe: PEST Analysis
    • Figure 7. Experts' Opinion
    • Figure 8. Europe Drug Delivery Market Impact Analysis of Drivers and Restraints
    • Figure 9. Europe Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
    • Figure 10. Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • Figure 11. Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 12. Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 13. Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 14. Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 15. Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 16. Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 17. Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 18. Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 19. Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 20. Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 21. Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 22. Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 23. Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 24. Pulmonary Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 25. Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 26. Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 27. Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 28. Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 29. Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 30. Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 31. Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 32. Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 33. Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 34. Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • Figure 35. Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 36. Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 37. Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 38. Europe Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
    • Figure 39. Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 40. Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 41. Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 42. Europe Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
    • Figure 43. Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
    • Figure 44. UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 45. Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 46. France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 47. Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 48. Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 49. Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 50. Growth Strategies in Europe Drug Delivery Market